Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tryn Stimart currently holds 4,646,012 shares of AbCellera Biologics Inc. (ABCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tryn Stimart has been a net seller of ABCL stock. They have purchased $10.0K and sold $25.5M worth of shares.
Tryn Stimart's most recent insider trade was on Jan 1, 2026, when they sold 539,265 shares at $0.00 per share.
Tryn Stimart serves as Executive at AbCellera Biologics Inc. (ABCL). They have executed 7 insider transactions totaling $25.5M over their tenure at the company.
Tryn Stimart holds the position of Executive at AbCellera Biologics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Tryn Stimart has shown a selling trading pattern, with $10.0K in total purchases and $25.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Tryn Stimart was on Jun 9, 2021, when they sold $25.5M worth of ABCL shares. This transaction involved 1,000,000 shares at $25.50 per share.
Tryn Stimart currently owns 4,646,012 shares of AbCellera Biologics Inc. (ABCL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tryn Stimart's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tryn Stimart has 7 Form 4 filings on record as an insider at AbCellera Biologics Inc..
Set alerts for Tryn Stimart and 40,000+ other insiders.